SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Themis Medicare - Quaterly Results

03 Feb 2023 Evaluate
The sales for the December 2022 quarter moved down to Rs. 887.80 millions as compared to Rs. 949.22 millions during the year-ago period.A slender decline of -0.55% was recorded to Rs. 120.86  millions from Rs. 121.53 millions in the corresponding previous quarter.The company reported a degrowth in operating Profit to 211.72 millions from 214.32 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202212 202112 % Var 202212 202112 % Var 202203 202103 % Var
Sales 887.80 949.22 -6.47 2742.18 3148.17 -12.90 3946.14 2306.70 71.07
Other Income 58.99 41.40 42.49 85.58 47.02 82.01 65.41 36.22 80.59
PBIDT 211.72 214.32 -1.21 655.35 859.31 -23.74 1021.92 535.06 90.99
Interest 22.27 21.25 4.80 68.56 68.46 0.15 87.74 127.12 -30.98
PBDT 189.45 193.07 -1.87 586.79 790.85 -25.80 934.18 407.94 129.00
Depreciation 26.74 23.65 13.07 76.98 70.90 8.58 94.80 85.46 10.93
PBT 162.71 169.42 -3.96 509.81 719.95 -29.19 839.38 322.48 160.29
TAX 41.85 47.89 -12.61 137.27 179.87 -23.68 223.81 56.28 297.67
Deferred Tax 0.85 7.89 -89.23 2.27 42.37 -94.64 56.31 56.28 0.05
PAT 120.86 121.53 -0.55 372.54 540.08 -31.02 615.57 266.20 131.24
Equity 92.00 91.99 0.01 92.00 91.99 0.01 92.00 91.88 0.13
PBIDTM(%) 23.85 22.58 5.62 23.90 27.30 -12.44 25.90 23.20 11.64

Themis Medicare Share Price

90.25 4.97 (5.83%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×